炎症因子在酒精性肝病发生发展中的作用

邱媛媛; 王伟恒; 朱樑

doi:10.3969/j.issn.1001-5256.2016.03.039

炎症因子在酒精性肝病发生发展中的作用

DOI: 10.3969/j.issn.1001-5256.2016.03.039

第二军医大学附属长征医院消化科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 1438
- HTML全文浏览量: 11
- PDF下载量: 369
- 被引次数: 0
出版历程
- 出版日期: 2016-03-20

Role of inflammatory factors in development and progression of alcoholic liver disease

Department of Gastroenterology, Changzheng Hospital, Second Military Medical University

摘要

摘要: 酒精性肝病（ALD）是全球范围内引起肝损伤的最常见疾病。炎症反应是引起ALD肝损伤的重要原因。酒精入肠后可使肠源性内毒素经肝肠循环入血增多,进而激活肝脏Kupffer细胞中Toll样受体4引起炎症因子的释放。肿瘤坏死因子α等炎症因子引起肝损伤,而白细胞介素（IL）6、10等通过调节炎症反应起到保护肝脏的作用。其中IL-6通过激活信号转导和转录激活因子（STAT）3通路上调肝细胞中多种抗损伤基因的表达,IL-10通过激活Kupffer细胞中STAT3抑制肝脏炎症反应。促炎因子和抗炎因子的失衡和再平衡的过程就是ALD的发展和转归过程。从炎症反应角度系统的综述了炎症因子在ALD发生发展中的作用。
- 肝疾病,酒精性 /
- 肿瘤坏死因子α /
- 白细胞介素6 /
- 白细胞介素10 /
- 综述
Abstract: Alcohol liver disease( ALD) is the most common disease resulting in liver injury in the world. Inflammatory response is an important reason for liver injury in ALD. After being absorbed into the intestines,alcohol can increase the amount of intestinal endotoxin which enters the bloodstream through enterohepatic circulation and activates Toll- like receptor 4 in liver Kupffer cells to release inflammatory factors. The inflammatory factors including tumor necrosis factor- α induce liver injury,while interleukin- 6( IL- 6) and interleukin- 10( IL- 10) protect the liver through regulating inflammatory response. IL- 6 can increase the expression of various anti- injury genes in hepatocytes through activating signal transducer and activator of transcription 3( STAT3),and IL- 10 can inhibit liver inflammatory response through activating STAT3 in Kupffer cells. The processes of imbalance and rebalance between proinflammatory factors and anti- inflammatory factors are the development and prognosis of ALD. This article systematically reviews the role of inflammatory factors in the development and progression of ALD from the perspective of inflammatory response.
- liver diseases,alcoholic /
- tumor necrosis factor-alpha /
- interleukin-6 /
- interleukin-10 /
- review

HTML全文

参考文献(37)

[1]ZIMMERMAN HJ.The evolution of alcoholic cirrhosis;clinical,biochemical and histologic correlations[J].Med Clin North Am,1955,12:241-259.

[2]TRIMBLE G,ZHENG L,MISHRA A,et al.Mortality associated with alcohol-related liver disease[J].Aliment Pharmacol Ther,2013,38(6):596-602.

[3]WANG H,MA L,YIN Q,et al.Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China[J].Alcohol Clin Exp Res,2014,38(4):1035-1041.

[4]KAWARATANI H,TSUJIMOTO T,DOUHARA A,et al.The effect of inflammatory cytokines in alcoholic liver disease[J].Mediators Inflamm,2013,2013:495156.

[5]SHEN JH,LI FF.Effect of jujube on the expression of CYP2E1 and TNFalpha in the hepatic tissue of mice with alcoholic liver disease[J].Chin J Integr Tradit West Med,2014,34(4):466-470.

[6]MAO X,WU Y,DIAO H,et al.Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model[J].Clin Rheumatol,2014,33(11):1585-1593.

[7]NEVE EP,INGELMAN-SUNDBERG M.Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane[J].J Biol Chem,2000,275(22):17130-17135.

[8]MCMULLEN MR,PRITCHARD MT,WANG Q,et al.Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice[J].Gastroenterology,2005,128(7):2066-2076.

[9]KEANE J,GERSHON S,WISE RP,et al.Tuberculosis associated with infliximab,a tumor necrosis factor alpha-neutralizing agent[J].N Engl J Med,2001,345(15):1098-1104.

[10]FELVER ME,MEZEY E,MCGUIRE M,et al.Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis[J].Alcohol Clin Exp Res,1990,14(2):255-259.

[11]YIN M,WHEELER MD,KONO H,et al.Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice[J].Gastroenterology,1999,117(4):942-952.

[12]JI C,DENG Q,KAPLOWITZ N.Role of TNF-alpha in ethanolinduced hyperhomocysteinemia and murine alcoholic liver injury[J].Hepatology,2004,40(2):442-451.

[13]HINES IN,WHEELER MD.Recent advances in alcoholic liver disease III.Role of the innate immune response in alcoholic hepatitis[J].Am J Physiol Gastrointest Liver Physiol,2004,287(2):g310-g314.

[14]FORSYTH CB,VOIGT RM,BURGESS HJ,et al.Circadian rhythms,alcohol and gut interactions[J].Alcohol,2015,49(4):389-398.

[15]ADACHI Y,MOORE LE,BRADFORD BU,et al.Antibiotics prevent liver injury in rats following long-term exposure to ethanol[J].Gastroenterology,1995,108(1):218-24.

[16]CHOUDHRY MA,FAZAL N,GOTO M,et al.Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury[J].Am J Physiol Gastrointest Liver Physiol,2002,282(6):g937-g947.

[17]MANDREKAR P,SZABO G.Signalling pathways in alcohol-induced liver inflammation[J].J Hepatol,2009,50(6):1258-1266.

[18]ALBANO E.Oxidative mechanisms in the pathogenesis of alcoholic liver disease[J].Mol Aspects Med,2008,29(1-2):9-16.

[19]DAVIS RJ.Signal transduction by the JNK group of MAP kinases[J].Cell,2000,103(2):239-252.

[20]WAN J,BENKDANE M,TEIXEIRA-CLERC F,et al.M2Kupffer cells promote M1 Kupffer cell apoptosis:a protective mechanism against alcoholic and nonalcoholic fatty liver disease[J].Hepatology,2014,59(1):130-142.

[21]FERNANDEZ-CHECA JC,KAPLOWITZ N,GARCIA-RUIZ C,et al.GSH transport in mitochondria:defense against TNF-induced oxidative stress and alcohol-induced defect[J].Am J Physiol,1997,273(1 Pt 1):g7-g17.

[22]CHAISSON ML,BROOLING JT,LADIGES W,et al.Hepatocyte-specific inhibition of NF-kappa B leads to apoptosis after TNF treatment,but not after partial hepatectomy[J].J Clin Invest,2002,110(2):193-202.

[23]ENDO M,MASAKI T,SEIKE M,et al.TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c(SREBP-1c)[J].Exp Biol Med(Maywood),2007,232(5):614-621.

[24]ATAIE-KACHOIE P,POURGHOLAMI MH,RICHARDSON DR,et al.Gene of the month:Interleukin 6(IL-6)[J].J Clin Pathol,2014,67(11):932-937.

[25]HILL DB,MARSANO L,COHEN D,et al.Increased plasma interleukin-6 concentrations in alcoholic hepatitis[J].J Lab Clin Med,1992,119(5):547-552.

[26]GAO B.Cytokines,STATs and liver disease[J].Cell Mol Immunol,2005,2(2):92-100.

[27]LI W,LIANG X,KELLENDONK C,et al.STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration[J].J Biol Chem,2002,277(32):28411-28417.

[28]MILLER AM,HORIGUCHI N,JEONG WI,et al.Molecular mechanisms of alcoholic liver disease:innate immunity and cytokines[J].Alcohol Clin Exp Res,2011,35(5):787-793.

[29]GALLUCCI RM,SLOAN DK,O'DELL SJ,et al.Differential expression of liver interleukin-6 receptor-alpha in female versus male ethanol-consuming rats[J].Alcohol Clin Exp Res,2004,28(3):365-373.

[30]TRIFUNOVIC J,MILLER L,DEBELJAK Z,et al.Pathologic patterns of interleukin 10 expression-a review[J].Biochem Med(Zagreb),2015,25(1):36-48.

[31]WEBER-NORDT RM,RILEY JK,GREENLUND AC,et al.Stat3 recruitment by two distinct ligand-induced,tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain[J].J Biol Chem,1996,271(44):27954-27961.

[32]MURRAY PJ.The JAK-STAT signaling pathway:input and output integration[J].J Immunol,2007,178(5):2623-2629.

[33]MCCLAIN CJ,HILL DB,SONG Z,et al.S-Adenosylmethionine,cytokines,and alcoholic liver disease[J].Alcohol,2002,27(3):185-192.

[34]KNOLLE P,SCHLAAK J,UHRIG A,et al.Human Kupffer cells secrete IL-10 in response to lipopolysaccharide(LPS)challenge[J].J Hepatol,1995,22(2):226-229.

[35] de WAAL MALEFYT R,ABRAMS J,BENNETT B,et al.Interleukin 10(IL-10)inhibits cytokine synthesis by human monocytes:an autoregulatory role of IL-10 produced by monocytes[J].J Exp Med,1991,174(5):1209-1220.

[36]HILL DB,D'SOUZA NB,LEE EY,et al.A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide[J].Alcohol Clin Exp Res,2002,26(1):74-82.

[37]WILLIAMS LM,RICCHETTI G,SARMA U,et al.Interleukin-10suppression of myeloid cell activation-a continuing puzzle[J].Immunology,2004,113(3):281-292.

施引文献

资源附件(0)

访问统计